Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Mycophenolate Mofetil as a Monotherapy in Multiple Sclerosis: a multicentre retrospective study on 361 patients
Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
Farming, Foreign Holidays, and Vitamin D in Orkney.
Is Poor Sleep Quality Associated With Greater Disability in Patients With Multiple Sclerosis?
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial.
Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity.
Preferred sources of health information in persons with multiple sclerosis: degree of trust and information sought.
Glial progenitor cell-based treatment of the childhood leukodystrophies.
Validation of White-Matter Lesion Change Detection Methods on a Novel Publicly Available MRI Image Database.
Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.
Effects of deep heating provided by therapeutic ultrasound on demyelinating nerves.
The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.
Can aerobic exercise alleviate flu-like symptoms following interferon beta-1a injections in patients with multiple sclerosis?
Gut microbiota in early pediatric multiple sclerosis: a case-control study.
Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.
Health literacy and patient safety: help patients understand
The Cost Burden of Switching Patients with Relapsing-Remitting Multiple Sclerosis from Glatiramer Acetate To Newly-Approved Disease Modifying Therapies.
High-throughput platforms for the screening of new therapeutic targets for neurodegenerative diseases.
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients
Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases.
Unilateral Optic Neuritis: A Rare Complication after Measles-Mumps-Rubella Vaccination in a 30-Year-Old Woman.
Behavioral assessment of neuropathic pain, fatigue, and anxiety in experimental autoimmune encephalomyelitis (EAE) and attenuation by interleukin-10 gene therapy.